You are on page 1of 2

- / rr~~~-~0

~~~~~~~
-
UNIVERSITY OF ZIMBABWE
2 017 May/June Examinations

F Science
acuity:.........................
Biochemistry
Department: ............................................................................................................................
BC1M01/BC1DM01 : Biochemistry
Paper code and Title: ........................................................................................................... .
3 hours
Duration: .................................................................................................................................
Dr C. Chidewe
Examiner: ................................................................................................................................
0
Authorized Materials: Calculator, Graph Paper

INSTRUCTIONS:

1. This paper contains 8 Questions


2. Answer 5 questions
3. Start each question on a new page
4. This question paper comprises 2 printed pages

NB: DO NOT TURN OVER THE QUESTION PAPER OR COMMENCE WRITING UNTIL
INSTRUCTED TO DO SO.
BC1M01/BC1DM01
PAGE ONE

1. Discuss the enterohepatic cycle of bile acids.


[20 marks]
2.
(a) Discuss any ONE of the following:

(i) phenylketonuria
(ii) albinism
(iii) maple syrup urine disease. (15 marks]
(b) Explain the clinical significance of transaminases. (5 marks]

3. Wri.t~ an account of thiamin (vitamin B1) including the functions, dietary sources,
positive and negative interactions and diseases that arise due to deficiency of the
vitamin. [20 marks]

4. Starting with the preparatory phase, describe how initiation of protein synthesis takes
place. Include the names of the components involved in this process. (20 marks]

5. Describe the role of vitamins and nutrients in iron metabolism and erythropoesis.
[20 marks)

6.
(a) "It is more important to know what sort of person has a disease than to know
what sort of disease a person has." Comment. [5 marks]

(b) Explain the measures to be taken prior to administration of antimetabolites


such as 6-mercaptopurine (6-MP) in the treatment of leukemias. [5 marks]

(c) Explain why the number of T-cells produced by people with a mutation in the
ADA gene is drastically reduced. [5 marks]

(d) Give an outline of a gene therapy protocol for the correction of the ADA gene.
[5 marks]
7.
(a) Explain how the absence of activity of hypoxanthine guanine
phosphoribosyl transferase (HGPRT) leads to Leasch-Nyhan syndrome and
eventually gout. [5 marks]

(b) Outline the biochemical mechanisms involved in cholera. [5 marks]

PLEASE TURN TO THE NEXT PAGE

You might also like